Clinical Trial Update: Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ascorbic acid to prevent postreperfusion syndrome in liver transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation
• Postreperfusion Syndrome

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: Hospital Universitario Ramon y Cajal | Conditions: Liver Transplantation, Postreperfusion Syndrome | Phase 2 | Status: UNKNOWN